Capsules: Health Care News and Ideas for Medical Conference Organizers

FDA NOTE The Coalition for Healthcare Communication (CHC) has released a position paper proposing new Food and Drug Administration guidelines for company dissemination of off-label (uses unapproved by the FDA) drug information. Recently, the U.S. District Court for the District of Columbia found that existing FDA guidelines and related provisions of the FDA Modernization Act are unconstitutional. The FDA has appealed the court's decision.